About Synnat Pharma
Synnat Pharma is a company based in Visakhapatnam (India) founded in 2011. It operates as a B2B. The company has 189 employees as of March 31, 2023. Synnat Pharma offers products and services including Active Pharmaceutical Ingredients, Intermediates, and Products Under Development. Synnat Pharma operates in a competitive market with competitors including Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
- Headquarter Visakhapatnam, India
- Employees 189 as on 31 Mar, 2023
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Synnat Pharma Private Limited
- Date of Incorporation 31 May, 2011
- Jurisdiction Serilingampally, Telangana, India
-
Annual Revenue
$7.68 M (USD)34.65as on Mar 31, 2023
-
Net Profit
$922.15 K (USD)46.65as on Mar 31, 2023
-
EBITDA
$2.23 M (USD)93.75as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
189
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Synnat Pharma
Synnat Pharma offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients, Intermediates, and Products Under Development.
Produces essential components for pharmaceutical drugs worldwide.
Manufactures precursors used in drug development processes.
Develops new pharmaceutical compounds for future markets.
Funding Insights of Synnat Pharma
Detailed funding history for Synnat Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Synnat Pharma
Investment portfolio details for Synnat Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Synnat Pharma
Detailed financials for Synnat Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Synnat Pharma Comparisons
Peer comparison for Synnat Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Synnat Pharma
Synnat Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| Locked | Locked | Locked |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| Locked | Locked | Locked |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| Locked | Locked | Locked |
Developer of drugs for the treatment of multiple disorders
|
|
| Locked | Locked | Locked |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
Detailed competitors of Synnat Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Synnat Pharma
Complete news archive for Synnat Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Synnat Pharma
Synnat Pharma was founded in 2011.
Synnat Pharma is headquartered in Visakhapatnam, India. It is registered at Visakhapatnam, Andhra Pradesh, India.
Ritesh Karnani is the current CEO of Synnat Pharma.
As of Mar 31, 2023, the latest employee count at Synnat Pharma is 189.
Annual revenue of Synnat Pharma is $7.68M as on Mar 31, 2023.
Synnat Pharma is a pharmaceutical company focused on producing active pharmaceutical ingredients and intermediates. It operates advanced manufacturing facilities in Visakhapatnam, India, with reactors ranging from 100 to 8000 liters. The company serves semi-regulated and non-regulated markets, emphasizing quality control and global supply. It also develops new products and maintains a professional team for operations.
Synnat Pharma's top competitors include Merck, Roivant Sciences and AbbVie.
Synnat Pharma offers Active Pharmaceutical Ingredients, Intermediates, and Products Under Development.